Neumora Therapeutics, Inc.(NASDAQ:NMRA) 
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.
Website: https://neumoratx.com/
Founded: 2019
IPO Price: $17 (Sep 15, 2023)
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.84
H 0.85
L 0.71
C 0.74
V 1,775,035
10EMA 0.74
20EMA 0.74
60EMA 0.74
120EMA 0.74
250EMA 0.74